Werlabs shares
Unlisted company
Werlabs is a digital healthcare provider registered with IVO that offers blood test-based health checks without a doctor's referral. The business operates through a proprietary digital platform where customers order health checks online, provide samples at one of the company’s affiliated sampling locations, and receive the results in a digital medical record with a doctor’s comments.
How the company makes money
Revenue is generated primarily through direct-to-consumer sales of health check packages and individual blood tests, complemented by a corporate segment in which employers purchase health checks for their employees. Pricing is per test or package, and the customer pays directly when placing the order. The company does not own any laboratories, instead purchasing analysis capacity from accredited laboratories, resulting in a variable cost structure linked to testing volumes.
Market and presence
The business operates in Sweden, with sampling locations from Luleå in the north to Malmö in the south. Its head office is located in Stockholm.
How the company grows
The company grows organically by expanding its product offering, increasing customer acquisition in both the consumer and corporate segments, and developing the digital platform. The platform is being expanded with data-driven health analysis, using the company’s accumulated test data to develop tools such as biological age and personalised health recommendations.
How the service works
Health checks without a doctor's referral
Healthcare provider registered with IVO
Digital medical record with a doctor’s comments
Revenue and costs
Payment per test or package
No in-house laboratories
Analysis by accredited laboratories
Financial performance
Published 28 August 2026Published figures from the company’s own reports. Amounts in MSEK · change from the previous year
- Cash and bank 2023-12-31
- 25MSEK
- Burn rate
- 2.7MSEK/mo
- Runway
- 9mo
- Equity ratio
- 66%
| Metric | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|
| Net sales | 104(+14.2 %) | 91(-19.1 %) | 113 | – |
| Revenue growth | 14.2%(+33.2 pp) | -19.1% | – | – |
| EBITDA | -8.4 | -27 | -24(-221.9 %) | 20 |
| EBIT | -8.5 | -27 | -24(-223.3 %) | 20 |
| Net income | -7.7 | -26 | -24(-223.3 %) | 20 |
| Equity | – | 25(-9.3 %) | 28(-45.3 %) | 51 |
| Cash and bank | – | 25(-25.8 %) | 34(-40.6 %) | 57(+50.1 %) |
| Operating cash flow | – | -32 | -24(-219.9 %) | 20(+33.4 %) |
| Equity ratio | – | 66%(+2.4 pp) | 63.6%(-7.3 pp) | 70.9% |
Documents and reports
4New share issues
Latest 1An overview of the company’s capital raising.
| Date | Capital raised | Valuation |
|---|---|---|
| SEK 15m | SEK 625m |
Questions about Werlabs
Is Werlabs publicly listed?
No, Werlabs is a private company and is not publicly listed. The company has not completed an IPO, so its shares are not traded on a regulated stock exchange, but rather on the private market.
What does Werlabs do?
Werlabs is a Swedish digital health company that offers health checks through blood tests, blood pressure measurements, and health questionnaires to individuals and companies. Samples are collected at affiliated testing locations throughout Sweden in partnership with accredited laboratories, and the results are presented in a digital medical record with a personalised comment from a doctor.
Can I buy shares in Werlabs?
Yes, it is possible to buy shares in Werlabs through unlisted share trading, provided that there are sellers. Through Eqvor, you can place a buy order and be matched with sellers in the unlisted market.
How do I sell shares in Werlabs?
If you own shares in Werlabs, you can place a sell order via Eqvor and be matched with buyers. Once the transaction has been completed, the shares are transferred in accordance with the company’s Euroclear-linked custody structure.
Is Werlabs affiliated with Euroclear?
Yes, Werlabs is affiliated with Euroclear. This means that the shares are handled within the Swedish securities system and can be transferred to a custody account with any bank or investment firm once the transaction has been completed.
Can I hold Werlabs shares with Avanza or Nordnet?
Yes, since Werlabs is affiliated with Euroclear, the shares can normally be held in a securities account with, for example, Avanza or Nordnet, provided that the bank or online broker supports the custody of unlisted shares.
Does Werlabs have any post-transfer purchase or pre-emption provisions?
No, according to the company information, Werlabs does not have any post-transfer purchase or pre-emption provisions. This means that share transfers normally do not need to be offered to existing shareholders before being sold to an external buyer.
At what price is Werlabs stock traded?
Since Werlabs is not publicly listed, there is no official share price on a regulated marketplace. Instead, the price is determined by supply and demand among buyers and sellers in the private market.
When will Werlabs be listed on the stock exchange?
There is currently no publicly announced timetable for a stock exchange listing of Werlabs. We therefore do not know when Werlabs may be listed or whether the company will carry out an IPO.
What are the risks of investing in Werlabs?
Investing in Werlabs involves risk, just like other investments in unlisted shares. The company’s valuation may be affected by demand for health screenings, competition in e-health, partnerships with laboratories, regulatory requirements, customer acquisition, margins, and developments in preventive care and digital health data. Trading in unlisted shares also typically involves lower liquidity than trading in publicly listed shares.
Where can I find Werlabs' annual report?
Werlabs' annual report can be found under Investor Relations and Financial Reports. The company's annual reports are available there for download.
Has Werlabs carried out any share issues?
Yes, Werlabs has carried out capital raises and previous new share issues. Werlabs Capital raised is stated as SEK 147.8 million, showing how much capital the company has raised through previous financing.
How much capital has Werlabs raised in total?
Werlabs’ Capital raised is stated as SEK 147.8 million. An equity raise is a term for raising capital, while terms such as funding round, financing, or share issue are also commonly used.
Has Werlabs reported a profit or a loss?
Werlabs reports a negative result in the latest available information. Under Key figures, EBITDA is stated as -8,394 TSEK and net income as -7,668 TSEK. The company’s earnings performance is also shown in the Results by year chart.